A detailed history of Bank Of America Corp transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,666 shares of PMN stock, worth $1,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,666
Previous 1,666 -0.0%
Holding current value
$1,566
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.97 - $2.0 $11,494 - $23,700
-11,850 Reduced 87.67%
1,666 $1,000
Q2 2023

Aug 14, 2023

SELL
$3.7 - $8.14 $4,436 - $9,759
-1,199 Reduced 8.15%
13,516 $52,000
Q1 2023

May 12, 2023

BUY
$4.06 - $5.71 $6,357 - $8,941
1,566 Added 11.91%
14,715 $69,000
Q4 2022

Feb 10, 2023

SELL
$4.33 - $6.29 $5,196 - $7,548
-1,200 Reduced 8.36%
13,149 $57,000
Q3 2022

Nov 14, 2022

BUY
$4.99 - $9.25 $71,601 - $132,728
14,349 New
14,349 $88,000

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.